Research and Markets: 2012 CRO Quality Benchmarking - Phase I Service Providers

Thu Feb 7, 2013 8:19am EST

* Reuters is not responsible for the content in this press release.

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130207:nBw075798a

DUBLIN--(Business Wire)--

Research and Markets

(http://www.researchandmarkets.com/research/pqp7x5/2012_cro_quality) has
announced the addition of the "2012 CRO Quality Benchmarking - Phase I Service
Providers" report to their offering. 

This report, like our other CRO Benchmarking reports, is intended to provide the
pharmaceutical and biotech industry and their service providers with
third-party, objective data to better evaluate, select, and improve clinical
outsourcing. This report focuses on providers of Phase I clinical pharmacology
services.

Publication Overview

WHAT YOU'LL LEARN 

For Sponsors: Make more informed CRO selection decisions by understanding which
Phase I CROs are the best fit for your individual organization's needs 

For Phase I Units: 

- Improve clinical pharmacology service quality and create loyal customers 

- Develop more effective RFP responses and increase new business wins 

- Better position your Phase I unit to the competition 

- Develop marketing messages that will resonate with your buyers 

ATTRIBUTES EVALUATED 

Each respondent was asked to rank the companies they have used in the past 18
months, across the following service quality attributes: 

- Quality of the Phase I unit's lead investigator 

- Quality of clinic staff 

- Technical expertise 

- Ability to quickly recruit volunteers or patients 

- Meeting schedules and timelines 

- Breadth of services 

- Range of tests, specialized equipment 

- Low cost 

- Overall value 

MAJOR SECTIONS 

Phase I Outsourcing Behaviors, Attitudes, Beliefs, and Intentions 

Phase I Service Provider Selection Drivers 

Phase I Service Provider Performance 

Study Data

Companies Mentioned

Companies Included:

- Chiltern 

- INC Research 

- Mepace 

- Premier Research 

- Rho 

- SGS Life Sciences 

- Siro Clinpharm 

- US Oncology

Companies with Full Profiles:

- Bioclinica 

- Cetero 

- Charles River 

- Covance 

- DCRI - Duke 

- ICON 

- PAREXEL 

- PharmaNet/i3 

- PPD 

- PRA 

- Quintiles

For more information visit

http://www.researchandmarkets.com/research/pqp7x5/2012_cro_quality

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology, Pharmaceuticals

Copyright Business Wire 2013